openheart.bmj10h
Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
Objective Anthracyclines are successfully used in cancer treatment, but their use is limited by their cardiotoxic side effects. Several risk factors for anthracycline-associated cardiomyopathy (AACM) ...
openheart.bmj2d
Daylight savings time and myocardial infarction
Background Prior research has shown a transient increase in the incidence of acute myocardial infarction (AMI) after daylight savings time (DST) in the spring as well as a decrease in AMI after ...
openheart.bmj2d
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing
Background The efficacy of paclitaxel-coated balloons (PCB) for restenosis prevention has been demonstrated in humans. However, the mechanism of action for sustained drug retention and biological ...
openheart.bmj6d
Left ventricular diastolic reserve in patients with type 2 diabetes mellitus
2 The George Institute, University of Sydney, Camperdown, New South Wales, Australia 3 Liverpool Diabetes Collaborative Research Unit, Ingham Institute, Liverpool, Sydney, New South Wales, Australia 4 ...
openheart.bmj6d
Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection
Objective This study aimed to assess the incidence of early cancer therapy-related cardiac dysfunction (CTRCD) and the characteristics of left and right heart deformations during anthracycline ...